Maker of popular coronavirus test told factory to destroy inventory
As coronavirus cases in the U.S. plummeted in the spring, so did Abbott Laboratories’ coronavirus-testing sales. But amid a new surge in infections, steps the...
The rationing of a last-resort COVID treatment is still ongoing
In the U.S., while ventilator shortages were largely averted in the pandemic, the therapy called ECMO remains scarce. Without national guidelines, many hospitals make their...
‘It takes time’: ICU workers help their former COVID-19 patients mend VIEW
Several medical centers around the country have created outpatient clinics for COVID-19 survivors, intended to address their lingering physical and psychic wounds — and to...
FDA’s emergency approval of blood plasma is now on hold
Donated by people who have survived COVID-19, antibody-rich plasma is considered safe. But clinical trials have not proved plasma can help people fighting the coronavirus.
A coronavirus death in early February was ‘probably the tip of an iceberg’
The unexpected new finding makes clear that the virus was circulating in the Bay Area of California as early as January, even before the U.S....
The lost month: How a failure to test blinded the U.S. to COVID-19
As the deadly virus from China spread with ferocity across the U.S. between late January and early March, large-scale testing of people who might have...
‘It’s just everywhere already’: How delays in testing set back the U.S. coronavirus response
The failure to tap into a Pacific Northwest flu study was one in a series of missed chances by the federal government to ensure more...